Overview

  • Product name
    Capsazepine
  • Description
    VR1 antagonist
  • Biological description
    VR1 vanilloid receptor antagonist (IC50 = 562 nM). Analgesic in vivo.
  • Purity
    > 99%

Properties

References

This product has been referenced in:
  • Menéndez L  et al. Analgesic effects of capsazepine and resiniferatoxin on bone cancer pain in mice. Neurosci Lett 393:70-3 (2006). Read more (PubMed: 16243435) »
  • Seabrook GR  et al. Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxin. J Pharmacol Exp Ther 303:1052-60 (2002). Read more (PubMed: 12438527) »
  • Walpole CS  et al. The discovery of capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxin. J Med Chem 37:1942-54 (1994). Read more (PubMed: 8027976) »
  • Perkins MN & Campbell EA Capsazepine reversal of the antinociceptive action of capsaicin in vivo. Br J Pharmacol 107:329-33 (1992). Read more (PubMed: 1422585) »

See all 7 Publications for this product

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab120025.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

Sign up